Dice CEO: Energy, T...
AngioDynamics Inc. (ANGO: NASDAQ)
$11.90 -0.14 | -1.16%
06/01/12 - 04:00 PM ET
Company Income Statement
| May 2011 | May 2010 | May 2009 | May 2008 | |
| Sales | 215.75M | 216.04M | 195.05M | 166.50M |
| Cost of Sales | 86.65M | 86.00M | 72.06M | 61.89M |
| Gross Operating Profit | 129.10M | 130.03M | 122.99M | 104.61M |
| Selling, General, and Administrative Expenses | 75.95M | 77.36M | 76.92M | 61.47M |
| Research & Development | 21.37M | 19.28M | 17.91M | 14.42M |
| Operating Income before D & A (EBITDA) | 31.78M | 33.40M | 28.16M | 28.71M |
| Depreciation & Amortization | 12.63M | 12.53M | 12.06M | 8.87M |
| Interest Income | 737.00K | 713.00K | 1.56M | 3.16M |
| Other Income - Net | -8.68M | -1.29M | -1.78M | -737.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | -3.61M |
| Total Income Before Interest Expenses (EBIT) | 11.20M | 20.29M | 15.88M | 18.66M |
| Interest Expense | 499.00K | 672.00K | 731.00K | 1.33M |
| Pre-Tax Income | 10.70M | 19.62M | 15.15M | 17.33M |
| Income Taxes | 2.58M | 7.31M | 5.22M | 6.44M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 8.12M | 12.31M | 9.93M | 10.89M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 8.12M | 12.31M | 9.93M | 10.89M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 8.12M | 12.31M | 9.93M | 10.89M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
8.12M | 12.31M | 9.93M | 14.50M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 8.12M | 12.31M | 9.93M | 10.89M |
| Basic EPS from Continuing Ops. | 0.33 | 0.50 | 0.41 | 0.45 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.33 | 0.50 | 0.41 | 0.45 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.33 | 0.50 | 0.41 | 0.45 |
| Basic Normalized Net Income/Share | 0.33 | 0.50 | 0.41 | 0.60 |
| EPS fr Continuing Ops. | 0.32 | 0.50 | 0.41 | 0.45 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.32 | 0.50 | 0.41 | 0.45 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.32 | 0.50 | 0.41 | 0.45 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.32 | 0.50 | 0.41 | 0.60 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ANGO
- Portfolio NameUser Type
- UserMedical devices M&A
- ContributorEarnings Short Squeeze Play...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserLast Day of the JPMorgan He...
- UserDrewski2 Portfolio 1
- Userwafessler Portfolio 1
- UserRPavlovic Portfolio 1
- UserGluck Portfolio 1
- Userchappervester Portfolio 1
Latest ANGO Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript 04.04.12 | 08:04 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 03.09.12 | 04:03 am
- AngioDynamics Inc. Presents At The 30th Annual JPMorgan Chase Healthcare Conference, Jan-12-2012 10:30 AM 01.12.12 | 08:01 pm
- AngioDynamics Inc. Stock Upgraded (ANGO) 01.09.12 | 05:01 am
- AngioDynamics' CEO Discusses Q2 2012 Results - Earnings Call Transcript 01.05.12 | 10:01 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 11.29.11 | 06:11 am
- AngioDynamics Inc. Stock Upgraded (ANGO) 10.26.11 | 07:10 am
- AngioDynamics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 10.06.11 | 09:10 pm
- 5 Earnings Stocks to Squeeze the Bears 10.04.11 | 01:10 pm
Press Releases for ANGO
- NanoKnife® System Clinical Experience Featured At Society Of Surgical Oncology Conference - Business Wire 04.02.12 | 06:04 am
- Five Oral Presentations On Clinical Experience With NanoKnife® System Featured At Society Of Interventional Radiology Conference - Business Wire 03.29.12 | 06:03 am
- AngioDynamics Establishes Strategic Relationship With Microsulis Medical Ltd. - Business Wire 03.26.12 | 06:03 am
- Scott Solano To Depart AngioDynamics - Business Wire 09.22.11 | 04:09 pm
- AngioDynamics Names Joseph M. DeVivo President And CEO - Business Wire 08.16.11 | 07:08 am
- AngioDynamics Reports Fiscal 2011 Fourth Quarter And Full Year Financial Results - Business Wire 07.14.11 | 04:07 pm
- AngioDynamics To Report Fiscal 2011 Fourth Quarter And Full Year Financial Results And Hold Conference Call On July 14, 2011 - Business Wire 07.05.11 | 06:07 am
- AngioDynamics Reports Preliminary Fiscal 2011 Fourth Quarter Financial Results And Corporate Developments - Business Wire 06.13.11 | 04:06 pm
- AngioDynamics Launches VenaCure® 1470nm Laser For Treatment Of Varicose Veins - Business Wire 05.31.11 | 06:05 am
- AngioDynamics Expands VenaCure EVLT® System For Varicose Veins With Longer 90 Cm Kit - Business Wire 05.26.11 | 06:05 am
Partner Headlines for ANGO
- The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases - Zacks 05.24.12 | 09:05 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- 6 Insider Stock Picks Rated Buy By Canaccord Genuity - Seeking Alpha 02.10.12 | 05:02 pm
- AngioDynamics Cuts View on Recall - Analyst Blog - Zacks 01.27.12 | 07:01 pm
- AngioDynamics Beats, Tweaks View - Analyst Blog - Zacks 01.06.12 | 09:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BSD Promotes Hyperthermia Tech - Analyst Blog - Zacks 10.31.11 | 07:10 pm
- Bard's 3Q Mixed, Buying Medivance - Analyst Blog - Zacks 10.26.11 | 09:10 am
- AngioDynamics Trades Lower on Q1 Earnings Results - Benzinga 10.06.11 | 04:10 pm
- Company News for June 16, 2011 - Corporate Summary - Zacks 06.16.11 | 10:06 am





